Yoshida H, Yokoyama K, Yaginuma T, Ohkido I, Yamamoto H, Utsunomiya Y, Kawakami M, Hosoya T
Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Clin Nephrol. 2011 Jan;75(1):1-7.
In patients with chronic kidney disease (CKD), coronary artery calcification occurs at two distinct sites in the vessel wall: the intima and the media. Arterial media calcification (AMC), a nonocclusive condition, affects hemodynamics differently compared to arterial intima calcification (AIC), which occurs in atherosclerotic plaques. Arterial calcification is considered a cell-regulated process resembling intramembranous bone formation. The purpose of this retrospective observational study was to clarify the morphological differences between AIC and AMC and to evaluate the role of vascular smooth muscle cells (VSMCs) and macrophages in AIC and AMC formation.
We histologically analyzed 14 tissue specimens from 14 autopsies of patients with CKD Stage 5D who underwent hemodialysis and 5 specimens from 5 patients with CKD Stage 2 - 3 (90 ml/min/1.73 m2 > estimated GFR >= 30 ml/min/1.73 m2). We performed immunohistochemical staining of osteopontin (OPN) as a marker for bone matrix protein, alpha-smooth muscle actin (alphaSMA) for VSMCs, Cbfa1/Runx2 as a marker for osteoblastic differentiation of VSMCs, and CD68 for macrophages.
In the CKD 2/3 group, we also found AIC and AMC. OPN and CD68 expression in the CKD 2/3 group was similar to that in the CKD 5D group. Although we did not find Cbfa1/Runx2 positive cell expression in the CKD 2/3 group, we did find it in the CKD 5D group. We found CD68-positive cells predominantly in AIC and absent in AMC in both groups.
These findings suggest that the influence of Cbfa1/Runx2 pathway in coronary artery calcification depends on the CKD Stage. Expression of CD68-positive cells depends on the location of the coronary artery calcification.
在慢性肾脏病(CKD)患者中,冠状动脉钙化发生在血管壁的两个不同部位:内膜和中膜。动脉中膜钙化(AMC)是一种非阻塞性病变,与发生在动脉粥样硬化斑块中的动脉内膜钙化(AIC)相比,对血流动力学的影响不同。动脉钙化被认为是一个类似于膜内骨形成的细胞调节过程。这项回顾性观察研究的目的是阐明AIC和AMC之间的形态学差异,并评估血管平滑肌细胞(VSMC)和巨噬细胞在AIC和AMC形成中的作用。
我们对14例接受血液透析的CKD 5D期患者尸检的14份组织标本以及5例CKD 2 - 3期(估计肾小球滤过率[GFR]>90 ml/min/1.73 m²且≥30 ml/min/1.73 m²)患者的5份标本进行了组织学分析。我们对骨桥蛋白(OPN)进行免疫组化染色,作为骨基质蛋白的标志物;对α-平滑肌肌动蛋白(αSMA)进行染色,用于标记VSMC;对Cbfa1/Runx2进行染色,作为VSMC成骨细胞分化的标志物;对CD68进行染色,用于标记巨噬细胞。
在CKD 2/3组中,我们也发现了AIC和AMC。CKD 2/3组中OPN和CD68的表达与CKD 5D组相似。虽然我们在CKD 2/3组中未发现Cbfa1/Runx2阳性细胞表达,但在CKD 5D组中发现了。我们发现两组中CD68阳性细胞主要存在于AIC中,而在AMC中不存在。
这些发现表明,Cbfa1/Runx2通路在冠状动脉钙化中的影响取决于CKD分期。CD68阳性细胞的表达取决于冠状动脉钙化的部位。